Post by
askretka on Sep 16, 2022 6:03am
05 September new RioGlio/ Pelareorep Article
https://academic.oup.com/neuro-oncology/article/24/Supplement_2/ii73/6692053 ------------------------------------- Another good article by Oncology virus expert Alan Melcher. Cheers!!!!!!
Comment by
Noteable on Sep 16, 2022 11:49am
In this ONCY ReoGlio study of newly diagnosed GBM patients, none of the 15 ReoGlio patients underwent debilitating surgery nor did they require followup chemoradiotherapy, whereas in the the 2018 retrospective study of 77 patients, all patients underwent surgery, as well as 2 courses of chemoradiotherapy (TMZ+ post-operative radiotherapy).
Comment by
Capitalista on Sep 16, 2022 3:17pm
Thanks for the comparative data, Noteable. This was not presented in Short et al's abstract (might have been in the article itself?) and was needed to put their results in context.